Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') is pleased to announce that ebdarokimab, an investigational monoclonal antibody developed by the company, has received marketing approval from the ...

Nika Beamon set out on a journey, and 26 doctors, 37 procedures and more than 17 years later, a rheumatologist finally ...

Today, we face a new pandemic: misinformation. Addressing it requires continuous engagement – and not just from doctors.

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

In Brazil, a group of researchers from the Federal University of São Paulo (UNIFESP) and the Butantan Institute have ...

Emerging biotech leader AKESF develops Ivonescimab & Cadonilimab; while offering growth potential with US partnerships, ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...

Continuous processing is a well-known technique for (mAb production, but has only begun attracting interest in AAV production.

Monoclonal antibodies (mAbs) are nature's biological ... Figure 1: Number of mAbs entering clinical studies by year. Although production of fully human mAbs from transgenic mice and phage display ...

The Biosimilars Market is valued at USD 34.61 Billion in 2024 and is expected to reach USD 205.65 Billion by 2035 at a CAGR ...